Expedited Review claims are paid the current Payment Percentage of the Scheduled Value for each disease as outlined in the TDP. Expedited Review is also intended to provide qualifying claimants a fixed and certain claim payment.  The current Payment Percentage is 60%.

Halliburton or Non-Harbison-Walker Entity Claims

Disease LevelScheduled Value
Mesothelioma  (Level VIII)
$58,349.72
Lung Cancer 1 (Level VII)
$9,486.93
Other Cancer  (Level V)
$8,160.80
Severe Asbestosis  (Level IV)
$9,588.94
Asbestosis/Pleural Disease (Level III)
$2,448.24
Asbestosis/Pleural Disease (Level II)
$1,122.11
Other Asbestos Disease (Level I)
$102.01

 

Harbison-Walker Entity Claims

Disease LevelScheduled Value
Mesothelioma (Level VIII)
$139,243.65
Lung Cancer 1 (Level VII)
$45,802.49
Other Cancer (Level V)
$24,482.40
Severe Asbestosis (Level IV)
$30,092.95
Asbestosis/Pleural Disease (Level III)
$7,334.72
Asbestosis/Pleural Disease (Level II)
$3,876.38
Other Asbestos Disease (Level I)
$306.03